Post by Merck on X
Merck@Merck
XToday, we announced positive topline results from our late-stage clinical study in respiratory syncytial virus (#RSV) disease. Learn more: t.co
25 likes2 repliesPosted Jul 23, 2024
ViralLoop
Your next post already worked.
Loading the post
Private to you, and used when you remix this post.
Analysis by ViralLoop — not written by the original author.